Medical Technology

Cypralis and Gilead Sciences, Inc. agree on license terms under which Cypralis will hold exclusive development and commercialization rights to certain jointly-owned ‘cyprolides’ for acute and chronic degenerative diseases

Mon, 08/01/2018 - 07:00

Cambridge, UK, 8th January 2017 / Sciad Newswire / Cypralis and Gilead Sciences, Inc.

Fri, 05/01/2018 - 08:00

London, UK, 5th January 2018 / Sciad Newswire / This January sees the third edition of Festival of Genomics Lond

Wed, 03/01/2018 - 11:30

Flanders, Belgium, 3rd January 2018 / Sciad Newswire / Bruges, Belgium will host the third edition of

Thu, 14/12/2017 - 07:30

London, UK, 14th December 2017 / Sciad Newswire / ‘Trends and truth in life science investment’ is the latest annual report, published by

Mon, 11/12/2017 - 10:00

Coventry, UK, 11th December 2017 / Sciad Newswire / Medherant, a leader in next-generation transdermal drug delivery, ha

Wed, 22/11/2017 - 11:49

London, UK, 22nd November 2017 / Sciad Newswire / Further insights from the podium as the Pharma Integrates pa

Mon, 20/11/2017 - 13:50

London, UK, 20th November 2017 / Sciad Newswire / Returning to London for its landmark sixth year, the annual

Fri, 17/11/2017 - 15:25

Coventry, UK, 17th November 2017 / Sciad Newswire / Medherant is delighted to announce they have been awarded the ‘Excel

Thu, 26/10/2017 - 07:30

London, UK, 26th October 2017 / Sciad Newswire / This year’s Pharma Integrates conference in London, 15th-16th Nove

Thu, 12/10/2017 - 16:15

London, UK, 12th October 2017 / Sciad Newswire / Industry leaders will discuss the future of healthcare at